19th International Conference on Pharmacovigilance and Pharmaceutical Testing
Conference Aims and Objectives
The ICPPT 2017: 19th International Conference on Pharmacovigilance and Pharmaceutical Testing aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacovigilance and Pharmaceutical Testing. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacovigilance and Pharmaceutical Testing.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmacovigilance and Pharmaceutical Testing are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.
All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be abstracted and indexed in the International Science Index , and submitted to be indexed in the Google Scholar, Scopus and Thomson Reuters. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk.
Special Journal Issues
ICPPT 2017 has teamed up with the Special Journal Issue on Pharmacovigilance and Pharmaceutical Testing. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.
|Abstracts/Full-Text Paper Submission Deadline||August 18, 2017|
|Notification of Acceptance/Rejection||August 31, 2017|
|Final Paper (Camera Ready) Submission & Early Bird Registration Deadline||November 10, 2017|
|Conference Dates||December 11-12, 2017|
Please ensure your submission meets WASET's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.
Please refer to the Paper Submission GUIDE before submitting your paper.
Selected Conference Papers
1)21st Century Biotechnological Research and Development Advancements for Industrial Development in India
2)Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
3)Management Software for the Elaboration of an Electronic File in the Pharmaceutical Industry Following Mexican Regulations
M. Peña Aguilar Juan, Ríos Hernández Ezequiel, R. Valencia Luis
4)Intellectual Property Rights and Health Rights: A Feasible Reform Proposal to Facilitate Access to Drugs in Developing Countries
M. G. Cattaneo
5)Preparation of Polymer-Stabilized Magnetic Iron Oxide as Selective Drug Nanocarriers to Human Acute Myeloid Leukemia
6)Formulation of Extended-Release Gliclazide Tablet Using a Mathematical Model for Estimation of Hypromellose
Farzad Khajavi, Farzaneh Jalilfar, Faranak Jafari, Leila Shokrani
7)Polydopamine Nanoparticle as a Stable and Capacious Nano-Reservoir of Rifampicin
Tasnuva Tamanna, Aimin Yu
8)Determinants of Profitability in Indian Pharmaceutical Firms in the New Intellectual Property Rights Regime
Shilpi Tyagi, D. K. Nauriyal
9)Quality Based Approach for Efficient Biologics Manufacturing
Takashi Kaminagayoshi, Shigeyuki Haruyama
10)Controlled Release of Glucosamine from Pluronic-Based Hydrogels for the Treatment of Osteoarthritis
Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
11)Use of Curcumin in Radiochemotherapy Induced Oral Mucositis Patients: A Control Trial Study
12)The Effect of a Three-Month Training Program on the Back Kyphosis of Former Male Addicts
M. J. Pourvaghar, Sh. Khoshemehry
13)Learners’ Violent Behaviour and Drug Abuse as Major Causes of Tobephobia in Schools
14)Radiochemical Purity of 68Ga-BCA-Peptides: Separation of All 68Ga Species with a Single iTLC Strip
Anton A. Larenkov, Alesya Ya Maruk
15)Treatment of Mycotic Dermatitis in Domestic Animals with Poly Herbal Drug
U. Umadevi, T. Umakanthan